Free Newsletter
SPOTLIGHT: India's Lupin buying Japanese generics maker
Free newsletter via e-mail
Tools
Apparently all of pharma is looking to Asia--even the Asians. India's Lupin paid $60 million for a 79 percent interest in the Japanese pharma Kyowa to establish a "beachhead in the second-largest pharmaceutical market." Release
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: